Gene therapy startup emerges with green light for first-of-its-kind trial

Vironexis Biotherapeutics emerged from stealth with plans to start what it claims will be the first-ever clinical trial testing a cancer immunotherapy delivered with the help of an adeno-associated virus, or AAV.